Retina China 2018, a prestigious meeting held March 28-30 in Qingdao, China, was well attended by retinal specialists from all over Asia with only a handful invited from the United States, including Dr. Karl Csaky, Managing & Medical Director of the Retina Foundation of the Southwest. Having been invited to present at this meeting, Dr. Csaky used this opportunity to speak about the new OCT-A machine recently acquired by the Retina Foundation. This new cutting-edge technology enables our researchers to obtain detailed information on the retinal layers, blood vessels, blood flow, and more in patients with age-related macular degeneration. Dr. Csaky’s talk highlighted the importance of this new technology in helping diagnose and treat patients with age-related macular degeneration.
About Dr. Karl G. Casky
Karl G. Csaky, M.D., Ph.D. is the Managing & Medical Director, Director of the Molecular Ophthalmology Laboratory, and the T. Boone Pickens Senior Scientist at the Retina Foundation of the Southwest. Dr. Csaky’s main area of research is age-related macular degeneration, on which he conducts both laboratory and clinical research.
About Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is the number one cause of vision loss for people over the age of 65. It is a common retinal disease that disrupts the central vision that is necessary for everyday tasks such as reading, writing, and driving. Age-related macular degeneration occurs when there is a loss of visual cells (rods and cones) from the macula, the central part of the retina.